{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:22:05Z","timestamp":1761895325575,"version":"3.44.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ad.2011.03.002","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T15:18:09Z","timestamp":1312384689000},"page":"487-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Conectivopat\u00edas y psoriasis"],"prefix":"10.1016","volume":"102","author":[{"given":"L.","family":"Cuesta-Montero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Belinch\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2011.03.002_bib0005","unstructured":"Sociedad Espa\u00f1ola de Reumatolog\u00eda. Manual SER de las enfermedades reum\u00e1ticas. 4.a ed. Madrid: M\u00e9dica Panamericana; 2004."},{"key":"10.1016\/j.ad.2011.03.002_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1468-3083.2001.00191.x","article-title":"Prevalence of psoriasis in Spain (Epiderma Project: Phase I)","volume":"15","author":"Ferr\u00e1ndiz","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2011.03.002_bib0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00296-008-0544-5","article-title":"Coexistence of five autoimmune diseases: diagnostic and therapeutic difficulties","volume":"28","author":"Wielosz","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ad.2011.03.002_bib0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1468-3083.2004.00916.x","article-title":"Coexistence of subacute cutaneous lupus erythematosus and psoriasis","volume":"18","author":"Ferahbas","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2011.03.002_bib0025","unstructured":"Sociedad Espa\u00f1ola de Reumatolog\u00eda. Estudio EPISER: Prevalencia de las enfermedades reum\u00e1ticas en la poblaci\u00f3n espa\u00f1ola. Espa\u00f1a: Merck, Sharp & Dohme; 2001."},{"key":"10.1016\/j.ad.2011.03.002_bib0030","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1191\/0961203303lu469xx","article-title":"Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features","volume":"12","author":"L\u00f3pez","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.ad.2011.03.002_bib0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1157\/13113285","article-title":"Polymyositis-Dermatomyositis: incidence in Spain (1997-2004)","volume":"129","author":"Vargas-Legu\u00e1s","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ad.2011.03.002_bib0040","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/pds.1660","article-title":"Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model","volume":"17","author":"Villaverde-Hueso","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ad.2011.03.002_bib0045","series-title":"Manual de Dermatolog\u00eda","first-page":"171","article-title":"Etiopatogenia, cl\u00ednica y diagn\u00f3stico","author":"Pedraz","year":"2010"},{"key":"10.1016\/j.ad.2011.03.002_bib0050","unstructured":"Wolf K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick. Dermatolog\u00eda en Medicina General. 7.a ed. Madrid: Editorial M\u00e9dica Panamericana; 2009."},{"key":"10.1016\/j.ad.2011.03.002_bib0055","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"36","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2011.03.002_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000251595","article-title":"The natural history of psoriasis in 5,600 patients","volume":"148","author":"Farber","year":"1974","journal-title":"Dermatologica"},{"key":"10.1016\/j.ad.2011.03.002_bib0065","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ad.2011.03.002_bib0070","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/6.5.813","article-title":"Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis","volume":"6","author":"Trembath","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ad.2011.03.002_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.0022-202X.2004.23511.x","article-title":"The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis","volume":"124","author":"Allen","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1747.2003.12094.x","article-title":"Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis","volume":"120","author":"Asumalahti","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ad.2011.03.002_bib0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jmg.2007.053595","article-title":"Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease","volume":"45","author":"Wolf","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.ad.2011.03.002_bib0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/jid.2008.297","article-title":"Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22","volume":"129","author":"Li","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2796.2009.02099.x","article-title":"Th 17 cells in rheumatoid arthritis and systemic lupus erythematosus","volume":"265","author":"Pernis","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.ad.2011.03.002_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ad.2011.03.002_bib0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ad.2011.03.002_bib0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdermsci.2010.08.016","article-title":"IL-21 in the pathogenesis and treatment of skin diseases","volume":"60","author":"Constanzo","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ad.2011.03.002_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ad.2011.03.002_bib0125","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nm.1995","article-title":"Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis","volume":"15","author":"Caruso","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.ad.2011.03.002_bib0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.it.2008.02.008","article-title":"Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses","volume":"29","author":"Monteleone","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ad.2011.03.002_bib0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/BOR.0b013e328304b6b5","article-title":"IL-17 and the Th17 lineage in systemic lupus erythematosus","volume":"20","author":"Garrett-Sinha","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/gut.2008.166918","article-title":"Genetic variants in the region harbouring IL2\/IL21 associated with ulcerative colitis","volume":"58","author":"Festen","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.ad.2011.03.002_bib0145","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/1744666X.4.5.565","article-title":"Genome-wide association scan in psoriasis: new insights into chronic inflammatory disease","volume":"4","author":"Schrodi","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ad.2011.03.002_bib0150","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.humimm.2007.01.009","article-title":"Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes","volume":"68","author":"Asano","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ad.2011.03.002_bib0155","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2654","article-title":"Testing for the association of the KIAA1109\/Tenr\/IL2\/IL21 gene region with rheumatoid arthritis in a European family-based study","volume":"11","author":"Teixeira","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ad.2011.03.002_bib0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000155744","article-title":"A common exonic variant of interleukin 21 confers susceptibility to atopic asthma","volume":"148","author":"Chatterjee","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ad.2011.03.002_bib0165","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.21749","article-title":"Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two year prospective study (the DAMAGE study cohort)","volume":"54","author":"Kirkham","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.03.002_bib0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.humimm.2010.01.010","article-title":"IL-21 regulates Th17 cells in rheumatoid arthritis","volume":"71","author":"Niu","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ad.2011.03.002_bib0175","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/art.22452","article-title":"Blockade of the interleukin-21\/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis","volume":"56","author":"Young","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.03.002_bib0180","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.imbio.2008.07.022","article-title":"Interferon-alpha controls IL-17 expression in vitro and in vivo","volume":"213","author":"Moschen","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.ad.2011.03.002_bib0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.sder.2006.08.004","article-title":"Update on connective tissue diseases in dermatology","volume":"25","author":"Costner","year":"2006","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.ad.2011.03.002_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0049-0172(05)80004-6","article-title":"The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity","volume":"24","author":"Lorber","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.03.002_bib0195","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0190-9622(08)81901-9","article-title":"Linear psoriasis associated with systemic lupus","volume":"30","author":"Baselga","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0200","first-page":"449","article-title":"Coexistent psoriasis and lupus erythematosus: what's happening?","volume":"36","author":"Hu","year":"1985","journal-title":"Cutis"},{"key":"10.1016\/j.ad.2011.03.002_bib0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/scientificamerican0492-92","article-title":"Superantigens in human disease","volume":"266","author":"Johnson","year":"1992","journal-title":"Sci Am"},{"key":"10.1016\/j.ad.2011.03.002_bib0210","first-page":"92","article-title":"Chronic lupus disseminatus and psoriasis vulgaris","volume":"15","author":"O\u2019Leary","year":"1936","journal-title":"Arch Dermatol Syphilol"},{"key":"10.1016\/j.ad.2011.03.002_bib0215","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/archderm.1980.01640300046015","article-title":"The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases","volume":"116","author":"Millns","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0220","first-page":"511","article-title":"Lupus erythematosus and psoriasis vulgaris","volume":"21","author":"Lynch","year":"1978","journal-title":"Cutis"},{"key":"10.1016\/j.ad.2011.03.002_bib0225","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-4362.1990.tb02565.x","article-title":"Annular pustular psoriasis and systemic lupus erythematosus","volume":"29","author":"Ronglioletti","year":"1990","journal-title":"Int J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.ad.2011.03.002_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/00015555195115","article-title":"The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders","volume":"195","author":"Zalla","year":"1996","journal-title":"Acta Derm Venereol"},{"year":"2006","series-title":"Lupus erythematosus","author":"Dubois El","key":"10.1016\/j.ad.2011.03.002_bib0235"},{"key":"10.1016\/j.ad.2011.03.002_bib0240","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0190-9622(83)70069-1","article-title":"Serologic studies in patients with lupus erythematosus and psoriasis","volume":"8","author":"Kulick","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0190-9622(84)80267-4","article-title":"The coexistence of systemic lupus erythematosus and psoriasis","volume":"10","author":"Hays","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0250","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1468-3083.2004.00817.x","article-title":"Psoriasis coexisting with subacute cutaneous lupus erythematosus","volume":"18","author":"Kontochristopoulos","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2011.03.002_bib0255","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaad.2004.04.007","article-title":"Collagen vascular diseases","volume":"51","author":"Callen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00128071-200708010-00007","article-title":"Coexistent psoriasis and lupus erythematosus treated with alefacept","volume":"8","author":"Berthelot","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0265","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0190-9622(98)70497-9","article-title":"Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus. Diagnostic criteria and therapeutic implications","volume":"38","author":"Chlebus","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0270","first-page":"48","article-title":"Coexistence of psoriatic arthritis and systemic lupus erythematosus","volume":"9","author":"Avriel","year":"2007","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ad.2011.03.002_bib0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/anr.1780320318","article-title":"Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis; case report and review of the literature","volume":"32","author":"Dowdy","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.03.002_bib0280","first-page":"3","article-title":"Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems","volume":"154","author":"Astudillo","year":"2003","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.ad.2011.03.002_bib0285","series-title":"Dermatology","first-page":"115","article-title":"Psoriasis","author":"Van del Kerkhof","year":"2008"},{"key":"10.1016\/j.ad.2011.03.002_bib0290","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-4362.1999.00574.x","article-title":"The in vitro effect of hydroxychloroquine on skin morphology in psoriasis","volume":"38","author":"Wolf","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0295","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2340\/00015555-0141","article-title":"Hydroxychloroquine in psoriasis: is it really harmful?","volume":"86","author":"Sorbara","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2011.03.002_bib0300","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0001-7310(09)70821-X","article-title":"Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology","volume":"100","author":"Puig","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2011.03.002_bib0305","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0149-2918(03)80313-2","article-title":"An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis","volume":"25","author":"Weinberg","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.ad.2011.03.002_bib0310","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.1365-2230.2003.01411.x","article-title":"Etanercept-induced systemic lupus erythematosus","volume":"28","author":"Swalw","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0315","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3346\/jkms.2006.21.5.946","article-title":"Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis","volume":"21","author":"Kang","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ad.2011.03.002_bib0320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0151-9638(05)79281-4","article-title":"Worsening of subacute lupus erythematosus induced by infliximab","volume":"132","author":"Vabre-Latre","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ad.2011.03.002_bib0325","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep080","article-title":"Anti-TNF-induced lupus","volume":"48","author":"Williams","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.ad.2011.03.002_bib0330","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1186\/ar1715","article-title":"Systemic lupus erythematosus induced by anti-tumor necrosis factor alpha therapy: a French national survey","volume":"2","author":"De Bandt","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ad.2011.03.002_bib0335","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus: issues in diagnosis and treatment","volume":"10","author":"Walling","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0340","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0345","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4045\/tidsskr.09.0184","article-title":"A man with erythrodermia, muscle weakness and weight loss","volume":"129","author":"Gran","year":"2009","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.ad.2011.03.002_bib0350","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2298\/VSP0405557P","article-title":"Psoriasis in a patient with dermatomyositis","volume":"61","author":"Pavlovic","year":"2004","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.ad.2011.03.002_bib0355","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0360","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.1994.03520240067043","article-title":"Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed","volume":"28","author":"Kasteler","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ad.2011.03.002_bib0365","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s10067-009-1244-6","article-title":"Gottrons's papule in amyopathic dermatomyositis mimicking psoriasis","volume":"28","author":"Haroon","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0370","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2133.1989.tb08198.x","article-title":"Hydroxyurea in the management of therapy resistant psoriasis","volume":"121","author":"Layton","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0375","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1365-2230.1999.00443.x","article-title":"Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis","volume":"24","author":"Varma","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0380","first-page":"353","article-title":"Dermatomyositis occurring during psoralen A (PUVA)","volume":"21","author":"Sinoway","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0385","first-page":"707","article-title":"Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis\/dermatomyositis","volume":"23","author":"Ochi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0390","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archderm.142.1.65","article-title":"Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis","volume":"142","author":"Edge","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0395","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","article-title":"Successful treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor alpha: preliminary observations","volume":"50","author":"Hengstman","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ad.2011.03.002_bib0400","first-page":"2855","article-title":"Cyclosporin A in the treatment of refractory adult polymyositis\/dermatomyositis: population based experience in 6 patients and literature review","volume":"27","author":"Qushmaq","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0405","first-page":"2139","article-title":"Cyclosporin A in treatment of refractory adult polymyositis\/dermatomyositis","volume":"28","author":"Wenzel","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0410","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1093\/ndt\/gfp416","article-title":"Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation","volume":"24","author":"Hurst","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ad.2011.03.002_bib0415","first-page":"382","article-title":"Rabdomi\u00f3lisis secundaria a interacci\u00f3n de estatinas con macr\u00f3lidos en un paciente con trasplante renal","volume":"4","author":"Valero","year":"2004","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.ad.2011.03.002_bib0420","first-page":"682","article-title":"Systemic scleroderma (progressive systemic sclerosis), chemical diabetes mellitus, psoriasis","volume":"103","author":"Sauter","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0425","first-page":"48","article-title":"A case of severe form of psoriasis and systemic scleroderma","volume":"5","author":"Korotkii","year":"1984","journal-title":"Vestn Dermatol Venerol"},{"key":"10.1016\/j.ad.2011.03.002_bib0430","first-page":"66","article-title":"Association of scleroderma and psoriasis","volume":"6","author":"Khamaganova","year":"1986","journal-title":"Vestn Dermatol Venerol"},{"key":"10.1016\/j.ad.2011.03.002_bib0435","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1346-8138.2000.tb02180.x","article-title":"A rare association of systemic sclerosis with psoriasis vulgaris","volume":"27","author":"Yamamoto","year":"2000","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0440","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/rheumatology\/39.2.213","article-title":"Psoriasis and diffuse systemic sclerosis: a report of three patients","volume":"39","author":"Harrison","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ad.2011.03.002_bib0445","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/ard.41.2.141","article-title":"Scleroderma and erosive polyarthritis: a disease entity?","volume":"41","author":"Armstrong","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2011.03.002_bib0450","first-page":"117","article-title":"La sacroileite sclerodermica. Una entita anatomo-radiologica non nota","volume":"42","author":"Valentini","year":"1990","journal-title":"Reumatismo"},{"key":"10.1016\/j.ad.2011.03.002_bib0455","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/03009740310002560","article-title":"Systemic sclerosis could mask the presentation of psoriasis in a patient with symptomatic and bilateral sacroiliitis","volume":"32","author":"Girolamo","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0460","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archderm.138.1.99","article-title":"Treatment of scleroderma","volume":"138","author":"Sapadin","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0465","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/000155501317140061","article-title":"Calcium channel blockers intake and psoriasis: a case-control study","volume":"81","author":"Cohen","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2011.03.002_bib0470","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1346-8138.1993.tb01392.x","article-title":"Cutaneous reactions induced by calcium cannel blocker: high frequency of psoriasiform eruptions","volume":"20","author":"Kitamura","year":"1993","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0475","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2133.2002.48848.x","article-title":"Sartans, angiotensin II receptor antagonists, can induce psoriasis","volume":"147","author":"Marquart-Elbaz","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0480","first-page":"19","article-title":"Psoriasis induced by losartan therapy: a case report and review of the literature","author":"Lamba","year":"2009","journal-title":"Am J Ther"},{"key":"10.1016\/j.ad.2011.03.002_bib0485","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.03.002_bib0490","first-page":"294","article-title":"Kidney crisis in systemic sclerosis","volume":"50","author":"Lewandowski","year":"2005","journal-title":"Rocz Akad Med Bialymst"},{"key":"10.1016\/j.ad.2011.03.002_bib0495","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3899\/jrheum.090227","article-title":"Psoriasis induced or aggravated by drugs","volume":"83","author":"Rongioletti","year":"2009","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.ad.2011.03.002_bib0500","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4615-4857-7_32","article-title":"Triggered psoriasis","volume":"455","author":"Wolf","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ad.2011.03.002_bib0505","first-page":"83","article-title":"Double disease in rheumatology: coexistence of rheumatoid arthritis and psoriatic arthritis","volume":"10","author":"Mazzucchelli","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0510","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/ard.2005.037424","article-title":"New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists","volume":"65","author":"Kary","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2011.03.002_bib0515","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-4632.2009.04200.x","article-title":"Coexistence of bullous rheumatoid neutrophilic dermatosis and palmoplantar pustulosis in a patient with rheumatoid arthritis","volume":"49","author":"Yamamoto","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2011.03.002_bib0520","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3904\/kjim.2010.25.2.224","article-title":"Inflammatory polyarthritis in a patient with psoriasis: is it psoriatic arthritis or rheumatoid arthritis?","volume":"25","author":"Kwan-Hoon","year":"2010","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ad.2011.03.002_bib0525","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1515\/CCLM.2007.027","article-title":"Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis","volume":"45","author":"Bizzaro","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ad.2011.03.002_bib0530","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.2005.040998","article-title":"Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation","volume":"65","author":"Alenius","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2011.03.002_bib0535","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ad.2010.01.015","article-title":"Psoriatic arthritis: what the dermatologist needs to know, part 1","volume":"101","author":"L\u00f3pez-Ferrer","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2011.03.002_bib0540","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.03.002_bib0545","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.21233","article-title":"Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.03.002_bib0550","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731011001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731011001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:57:16Z","timestamp":1757552236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731011001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":110,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0001731011001384"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2011.03.002","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conectivopat\u00edas y psoriasis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2011.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Espa\u00f1a, S.L. y AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}